FMIPA UI Lecturer Receives International Award for Breakthrough in Cancer Therapy

Kyoto, 13 November 2025 – Dr. Deni Hardiansyah, S.Pd., M.Si., a lecturer at the Department of Physics, Faculty of Mathematics and Natural Sciences, Universitas Indonesia (FMIPA UI), has received the 2025 Asian and Oceanian Young Investigator Award (AOYIA) – Gold Prize. Dr. Deni is the first researcher from Indonesia and ASEAN to achieve this accomplishment, as previous AOYIA recipients have mostly come from countries such as Korea and India.

This prestigious award was presented by the Japanese Society of Nuclear Medicine (JSNM) to outstanding young researchers in the field of nuclear medicine and was awarded directly at the Kyoto International Exhibition Hall Miyako Messe on Thursday (13 November 2025). AOYIA is an annual award given to the best young researchers from the Asia–Oceania region.

Dr. Deni received the award thanks to his collaborative research with Prof. Gerhard Glatting from Medical Radiation Physics, Department of Nuclear Medicine, Ulm University, as well as Prof. Michael Mix from the Department of Nuclear Medicine, Medical Center, Freiburg University.

The results of the research have been published in one of the leading nuclear medicine journals in the United States. In this study, Dr. Deni developed a population-based pharmacokinetic method for cancer therapy planning, which has been proven to provide a higher level of accuracy compared to conventional approaches.

“The previous method modeled pharmacokinetic data for each patient individually, resulting in a limited number of parameters and lower accuracy. With the population-based approach, data from many patients are modeled simultaneously, allowing for a greater number of parameters and more realistic results,” said Dr. Deni, explaining the advantages of the pharmacokinetic method.

This approach allows cancer therapy planning to become more precise, reduces the number of patient visits to the hospital, and lowers both costs and radiation exposure.

“Patients who previously had to come back 3–5 times now only need a single imaging session,” he told the FMIPA UI Public Relations team.

“This method is more efficient and has the potential to transform cancer therapy practices, especially in developing countries,” he added. He also plans to expand the application of this method in clinical settings and strengthen international collaborations.

Dr. Deni’s achievement received appreciation from the FMIPA UI leadership. The Dean of FMIPA UI, Prof. Dede Djuhana, Ph.D., stated, “We are proud of Dr. Deni’s accomplishment. This award reinforces the international-caliber quality of FMIPA UI’s young researchers and highlights our active role in advancing scientific knowledge with broad benefits, particularly in the medical field.”

According to Prof. Dede, this achievement also reflects the quality of education and research at FMIPA UI, which emphasizes not only the mastery of knowledge but also its application in addressing real challenges in society.